Edaravone and Dexborneol Sublingual Tablet for Treating Chemotherapy- Induced Cognitive Impairment Study
Clinical trial NCT07454473 · RECRUITING
Trial details
- NCT number
- NCT07454473
- Sponsor
- Chuansheng Zhao
- Status
- RECRUITING
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2026-03-02
- Primary completion
- 2027-12-31
- Enrollment
- 80
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.